CX3CR1 and amyotrophic lateral sclerosis: The results of the genetic analyses of the CX3CR1 variants using a single marker or haplotype did not show any statistically significant difference for an earlier age at onset of ALS, or predict the site of clinical onset in any of the analyzed groups (wALS, sALS and fALS).